0.3906USD-7.79%Mkt Cap: 4.33M $P/E: —2d ago
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical profes…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap4.33M $
Enterprise Value4.68M $
Revenue (TTM)1.93M $
Gross Profit153.00K $
Net Income (TTM)-18.18M $
Revenue/Share0.6760 USD
Last Price0.3906 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees12
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.33
EV/Revenue2.43
P/S2.31
P/B0.05
EPS (TTM)-23.38
EPS (Forward)—
52W Range
0.29001% of range17.40
52W High17.40 USD
52W Low0.2900 USD
Profitability
Gross Margin5.99%
Oper. Margin-2290.38%
EBITDA Margin0.00%
Profit Margin-712.30%
ROE-54.29%
ROA-44.22%
Growth
Revenue Growth-51.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.37M $
CapEx (TTM)60.00K $
FCF Margin-408.75%
FCF Yield-181.83%
Net Debt226.00K $
Net Debt/EBITDA-0.02
Balance Sheet
Debt/Equity0.04
Current Ratio0.66
Quick Ratio0.18
Book Value/Sh8.651 USD
Cash/Share0.0980 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateAug 12, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.11.08M
Float11.08M
Insiders16.41%
Institutions2.66%
Short Interest
Short Ratio0.2d
Short % Float0.81%
Short % Out.0.81%
Shares Short74.96K
Short (prev mo.)60.84K
Technical
SMA 500.4947 (-21.0%)
SMA 2001.895 (-79.4%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)524.41K
Avg Vol (10d)2.97M
Technical Indicators
RSI (14)43.4
MACD-0.0230
MACD Signal-0.0405
MACD Hist.+0.0175
BB Upper0.4602 USD
BB Middle0.3823 USD
BB Lower0.3044 USD
BB Width40.76%
ATR (14)0.0523 USD
Vol Ratio (20d)0.10x